FDA Warning Letter — Exxon/Glenmore Tiger Mart

Case 656837 — FEI 3011377399

The FDA took a Warning Letter action against Exxon/Glenmore Tiger Mart on Apr 18, 2023 (Baltimore, MD). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon/Glenmore Tiger Mart
Date
Apr 18, 2023
Fiscal Year
2023
Product Type
Tobacco
Center
CTP
Location
Baltimore, MD (United States)